wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26743743-65A69D74-5A1C-4F42-B8DA-FFC046AEF496
Q26743743-65A69D74-5A1C-4F42-B8DA-FFC046AEF496
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26743743-65A69D74-5A1C-4F42-B8DA-FFC046AEF496
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers
P2860
Q26743743-65A69D74-5A1C-4F42-B8DA-FFC046AEF496
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26743743-65A69D74-5A1C-4F42-B8DA-FFC046AEF496
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e3b811cbd4211344e5b999e74083a74a19c6952
P2860
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.